- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05511220
Pivotal Response Intervention Minimal Responders Study (PRIMeR)
August 19, 2022 updated by: Dr. Isabel Smith, IWK Health Centre
Amplifying Treatment Response in Early Intervention 'Minimal Responders' With Autism Spectrum Disorder: A Virtual Parent-Coaching Intervention
Early intervention (EI) using naturalistic behavioural methods have shown benefits for the development of communication and other skills for young children with autism spectrum disorder.
The publicly funded autism EI program in Nova Scotia (NS) is based on such a method, Pivotal Response Treatment (PRT), and pre-post studies indicate benefits for children and families.
However, not all children benefit equally.
In this study, the investigators test the efficacy of a brief parent-mediated intervention designed to prime responsivity to PRT in children with a minimal responder profile derived from previous studies of the PRT-based EI program.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Investigators will enroll preschoolers with the minimal responder profile who are scheduled to begin the PRT-based public EI program.
Consenting parents will be offered a virtual intervention in which they will be randomized to 1 of 2 arms to receive coaching in either (a) PRIMeR intervention, designed to target areas of weakness in the minimal responder profile, or (b) PRT, the treatment model used in the EI program.
Coaching will take place on a virtual (video-conferencing) platform.
Each child's progress on treatment targets will be assessed in a single case experimental design (SCED) using data from blind-coded video-recordings of parent-child play episodes using a standard set of toys.
Overall study effects will be based on aggregated data for an anticipated n of 20 participants assigned to each arm (4 SCED series with 5 participants each contributing to each arm).
The primary outcome is gains in children's social initiations (video-coded); the secondary outcome is gains in children's communication levels (multi-method assessment).
Mixed methods will be used to evaluate aspects of parents' experiences,
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Isabel M Smith, PhD
- Phone Number: 902-470-7275
- Email: isabel.smith@iwk.nshealth.ca
Study Locations
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3K 6R8
- Recruiting
- IWK Health Centre
-
Contact:
- Isabel M Smith, PhD
- Phone Number: 902-470-7275
- Email: isabel.smith@iwk.nshealth.ca
-
Contact:
- Kathryne MacLeod, BSc
- Phone Number: 902-470-7275
- Email: kathryne.macleod@iwk.nshealth.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 5 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- upcoming enrollment in NS EI program for preschoolers with autism spectrum disorder (ASD), based on confirmed or provisional ASD diagnosis by a qualified clinician
- significant delay in cognitive abilities (assessed formally by psychologist or estimated by psychologist or developmental pediatrician at time of diagnosis)
- current spontaneous functional use of ≤ 10 words (clinician's observations; parent report using MacArthur-Bates Communicative Development Inventory - Words & Gestures (CDI-WG)
- limited use of toys / objects (clinician's impression or parent's report with no contrary observation by clinician)
- low levels of expressed positive affect (smiles, laughter) or limited positive and high negative affect (clinician's impression or parent's report with no contrary observation by clinician)
Exclusion Criteria:
- Severe sensory or motor impairment in child
- Parent unable to complete consent process (and receive coaching) in English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: PRIMeR
Virtual parent coaching in use of a novel intervention consisting of Social Routines and Reciprocal Imitation Training strategies
|
Virtual PRIMeR intervention consists of coaching parents to use strategies derived from Social Routines (to boost positive affect) and Reciprocal Imitation Training (to boost toy play)
Other Names:
|
Active Comparator: PRT
Virtual parent coaching in use of Pivotal Response Treatment strategies
|
Virtual PRT intervention consists of coaching parents to use key PRT strategies to enhance children's communication skills
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social initiations
Time Frame: Assessed at baseline, entry to EI program, and after 6 months of EI program
|
Change in frequency of child's social initiations toward parent, blind-coded from video sample
|
Assessed at baseline, entry to EI program, and after 6 months of EI program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Communication
Time Frame: Assessed at baseline, entry to EI program, and after 6 months of EI program
|
Change in level of communication derived from Assessment of Phase of Preschool Language (APPL)
|
Assessed at baseline, entry to EI program, and after 6 months of EI program
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Isabel M Smith, PhD, IWK Health Centre and Dalhousie University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 12, 2022
Primary Completion (Anticipated)
October 1, 2024
Study Completion (Anticipated)
March 30, 2025
Study Registration Dates
First Submitted
August 5, 2022
First Submitted That Met QC Criteria
August 19, 2022
First Posted (Actual)
August 22, 2022
Study Record Updates
Last Update Posted (Actual)
August 22, 2022
Last Update Submitted That Met QC Criteria
August 19, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1027196
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder With Impaired Functional Language
-
Rutgers, The State University of New JerseyRecruitingDepression | Autism Spectrum Disorder | Autism | Autism Spectrum Disorder With Impaired Functional LanguageUnited States
-
Holland Bloorview Kids Rehabilitation HospitalUniversity of Alberta; University of Toronto; Dalhousie University; IWK Health... and other collaboratorsRecruitingAutism Spectrum Disorder | Social Communication Disorder | Autism-Related Speech Delay | Autism Spectrum Disorder With Impaired Functional Language | Autism or Autistic TraitsCanada
-
National Institute of Mental Health (NIMH)CompletedAutism | Language Development | Toddlers | Language AcquisitionUnited States
-
Icahn School of Medicine at Mount SinaiResearch Foundation for Mental Hygiene, Inc.; Autism Science Foundation; The...RecruitingAutism Spectrum Disorder | FOXP1 | Mental Retardation With Language Impairment and With or Without Autistic FeaturesUnited States
-
Etablissement Public de Santé Barthélemy DurandNot yet recruitingNeurocognitive Disorders | Autism Spectrum Disorder | Language Development | Child LanguageFrance
-
ACADIA Pharmaceuticals Inc.RecruitingIrritability Associated With Autism Spectrum DisorderUnited States, Spain, France, Hungary, Poland, Italy
-
ACADIA Pharmaceuticals Inc.RecruitingIrritability Associated With Autism Spectrum DisorderUnited States, Spain, France, Australia, Poland, Italy, Hungary
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/SCompletedIrritability Associated With Autism Spectrum Disorder (ASD)United States
-
Jazz PharmaceuticalsGW ResearchTerminatedAutism Spectrum Disorder | ASD | Irritability Associated With Autism Spectrum DisorderUnited States
-
National Cheng-Kung University HospitalCompletedChildren With Autism Spectrum Disorder | Typical Developed ChildrenTaiwan
Clinical Trials on PRIMeR
-
University of BaghdadRecruitingWhite Spot Lesion of ToothIraq
-
Bradford Teaching Hospitals NHS Foundation TrustUnknownBracket Failure Rate | Bonding Time Per Bracket | Adhesive Remnant Index for Type of Bond Failure | Length of Treatment | Peer Assessment Rating
-
VA Puget Sound Health Care SystemCompleted
-
Canadian Immunization Research NetworkCHU de Quebec-Universite Laval; McGill University Health Centre/Research Institute... and other collaboratorsCompleted
-
Walter Reed National Military Medical CenterUniversity of Wisconsin, MilwaukeeCompletedHypertension | Cardiovascular Disease | Diabetes Mellitus | Osteoarthritis | Chronic Disease | Hyperlipidemia | COPDUnited States
-
Universidad Autonoma de San Luis PotosíUnknownTooth DemineralizationMexico
-
Parc Sanitari Sant Joan de DéuCompletedMental Health Disorder
-
University of KielIvoclar Vivadent AGUnknownRestauration in Situ | Final Loss of Restauration | Debonded Restauration
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific
-
Kastle Therapeutics, LLCIonis Pharmaceuticals, Inc.CompletedMetabolic Diseases | Congenital Abnormalities | Infant, Newborn, Diseases | Genetic Diseases, Inborn | Dyslipidemias | Metabolism, Inborn Errors | Lipid Metabolism Disorders | Hypercholesterolemia | Hyperlipidemias | Hyperlipoproteinemias | Lipid Metabolism, Inborn Errors | Hyperlipoproteinemia Type II | Metabolic... and other conditionsUnited States, Taiwan, Brazil, Canada, South Africa, United Kingdom, Singapore